KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 146 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $164,680 | -68.1% | 92,000 | -30.6% | 0.00% | -60.0% |
| Q1 2023 | $515,814 | +66.2% | 132,600 | +45.2% | 0.01% | +66.7% |
| Q4 2022 | $310,420 | +169.4% | 91,300 | +332.7% | 0.00% | +200.0% |
| Q3 2022 | $115,206 | -58.4% | 21,100 | -51.0% | 0.00% | -50.0% |
| Q4 2021 | $277,000 | -61.1% | 43,100 | -64.8% | 0.00% | -71.4% |
| Q3 2021 | $712,000 | +193.0% | 122,300 | +420.4% | 0.01% | +250.0% |
| Q2 2021 | $243,000 | – | 23,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |